DK15088D0 - Antibakterielt lyofiliseret praeparat - Google Patents

Antibakterielt lyofiliseret praeparat

Info

Publication number
DK15088D0
DK15088D0 DK015088A DK15088A DK15088D0 DK 15088 D0 DK15088 D0 DK 15088D0 DK 015088 A DK015088 A DK 015088A DK 15088 A DK15088 A DK 15088A DK 15088 D0 DK15088 D0 DK 15088D0
Authority
DK
Denmark
Prior art keywords
lyophilized preparation
antibacterial
antibacterial lyophilized
aspoxicillin
preparation
Prior art date
Application number
DK015088A
Other languages
English (en)
Other versions
DK15088A (da
Inventor
Keiichi Kohno
Hiroshi Miura
Yoshiyuki Hirakawa
Toshiyuki Ueki
Seiichi Morikuni
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of DK15088D0 publication Critical patent/DK15088D0/da
Publication of DK15088A publication Critical patent/DK15088A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK015088A 1987-01-14 1988-01-13 Antibakterielt lyofiliseret praeparat DK15088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62006868A JPS63174927A (ja) 1987-01-14 1987-01-14 抗菌性凍結乾燥製剤

Publications (2)

Publication Number Publication Date
DK15088D0 true DK15088D0 (da) 1988-01-13
DK15088A DK15088A (da) 1988-07-15

Family

ID=11650214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK015088A DK15088A (da) 1987-01-14 1988-01-13 Antibakterielt lyofiliseret praeparat

Country Status (18)

Country Link
US (1) US4966899A (da)
EP (1) EP0278243B1 (da)
JP (1) JPS63174927A (da)
KR (1) KR930001830B1 (da)
CN (1) CN1024754C (da)
AT (1) ATE61222T1 (da)
AU (1) AU597463B2 (da)
CA (1) CA1308358C (da)
DE (1) DE3861866D1 (da)
DK (1) DK15088A (da)
ES (1) ES2031930T3 (da)
FI (1) FI89454C (da)
GR (1) GR3001565T3 (da)
HK (1) HK63592A (da)
HU (1) HU197985B (da)
IE (1) IE60049B1 (da)
IL (1) IL85031A (da)
SG (1) SG60292G (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048263T3 (es) * 1988-11-01 1994-03-16 Sanol Arznei Schwarz Gmbh Composicion liofilizada de mdm y metodo para su fabricacion.
ES2183874T3 (es) * 1994-05-02 2003-04-01 Shionogi & Co Cristal derivado de pirrolidylthiocarbapenem, preparado liofilizado conteniendo dicho cristal y procedimiento para su produccion.
US8252228B1 (en) * 2008-10-13 2012-08-28 Abbott Cardiovascular Systems Inc. Methods for sterilizing carriers for treatment of a kidney
CN102372727A (zh) * 2010-08-10 2012-03-14 海南美好西林生物制药有限公司 一种阿扑西林钠的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733404A (en) * 1970-09-04 1973-05-15 Squibb & Sons Inc Antibacterial composition containing alpha-aminobenzyl penicillins
US4053609A (en) * 1975-09-12 1977-10-11 Tanabe Seiyaku Co., Ltd. Penicillins and processes for preparing the same
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
GB1539510A (en) * 1976-08-23 1979-01-31 Beecham Group Ltd Injectable compositions
JPS5640686A (en) * 1979-09-11 1981-04-16 Tanabe Seiyaku Co Ltd Purification of penicillin derivative
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof

Also Published As

Publication number Publication date
ES2031930T3 (es) 1993-01-01
DE3861866D1 (de) 1991-04-11
AU597463B2 (en) 1990-05-31
AU1022688A (en) 1988-07-21
FI89454B (fi) 1993-06-30
CA1308358C (en) 1992-10-06
FI89454C (fi) 1993-10-11
FI880027A (fi) 1988-07-15
KR930001830B1 (ko) 1993-03-15
HK63592A (en) 1992-08-28
FI880027A0 (fi) 1988-01-06
DK15088A (da) 1988-07-15
EP0278243B1 (en) 1991-03-06
IE880049L (en) 1988-07-14
HUT46212A (en) 1988-10-28
CN1034131A (zh) 1989-07-26
JPS63174927A (ja) 1988-07-19
GR3001565T3 (en) 1992-11-23
EP0278243A1 (en) 1988-08-17
CN1024754C (zh) 1994-06-01
ATE61222T1 (de) 1991-03-15
US4966899A (en) 1990-10-30
SG60292G (en) 1992-09-04
KR880008812A (ko) 1988-09-13
HU197985B (en) 1989-07-28
IL85031A (en) 1992-07-15
JPH053847B2 (da) 1993-01-18
IE60049B1 (en) 1994-05-18

Similar Documents

Publication Publication Date Title
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
CA2122612A1 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
ZA885192B (en) Pharmaceutical preparations
FI905956A0 (fi) Foerfarande foer producering av ett biologiskt aktivt protein.
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
ES2102393T3 (es) Complejos de acido quinolona carboxilico--ion metalico--acido.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
DK15088A (da) Antibakterielt lyofiliseret praeparat
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
KR910005886A (ko) 안정화 백혈구 인터페론
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
EP0189587A3 (en) Method of sterilizing recombinant microorganism
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment